Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2025-12-24 @ 12:34 PM
Study NCT ID:
NCT01562561
Status:
COMPLETED
Last Update Posted:
2017-02-20
First Post:
2012-03-22
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2002-12-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-12-20
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-22
First Submit QC Date:
None
Study First Post Date:
2012-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-17
Last Update Post Date:
2017-02-20
Last Update Post Date Type:
ACTUAL